Flowing cells through pulsed electric fields efficiently purges stem cell preparations of contaminating myeloma cells while preserving stem cell function

Blood

Volumn 105, Issue 5, 2005, Pages 2235-2238

  Craiu, Abie ^b   Saito, Yoriko ^b   Limon, Ana ^b   Eppich, Henry M ^b   Olson, Douglas P ^b   Rodrigues, Neil ^b   Adams, Gregor B ^b   Dombkowski, David ^b   Richardson, Paul ^b   Schlossman, Robert ^b   Choi, Peter S ^b   Grogins, Jonathan ^b   O'Connor, Paula G ^b   Cohen, Kenneth ^b   Attar, Eyal C ^b   Freshman, Jay ^b   Rich, Rebecca ^b   Mangano, Joseph A ^b   Gribben, John G ^b   Anderson, Kenneth C ^b   Scadden, David T ^a   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD; BONE MARROW CELL; CELL FUNCTION; CELL MEMBRANE; CELL MOTILITY; CELL SIZE; CONTROLLED STUDY; DEPLETION; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; MYELOMA CELL; PRIORITY JOURNAL; PULSED ELECTRIC FIELD; STEM CELL; TUMOR GROWTH; ANIMAL; AUTOTRANSPLANTATION; BONE MARROW; BONE MARROW PURGING; CELL SEPARATION; CYTOLOGY; ELECTROPORATION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LEUKAPHERESIS; METHODOLOGY; MOUSE; NONOBESE DIABETIC MOUSE; PATHOLOGY;

ANIMALS; BLOOD; BONE MARROW; BONE MARROW PURGING; CELL SEPARATION; CELL SIZE; ELECTROPORATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; MICE; MICE, INBRED NOD; MULTIPLE MYELOMA; TRANSPLANTATION, AUTOLOGOUS;

EID: 20144364361     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-12-4399     Document Type: Article

References (21)

1. Van Besien K, Loberiza FR, Bajorunaite R, et al. Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. Blood. 2003;102:3521-3529.
2. Gertz MA, Witzig TE, Pineda AA, Greipp PR, Kyle RA, Litzow MR. Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse free survival after transplantation. Bone Marrow Transplant. 1997;19:337-342.
3. Brenner MK, Rill DR, Moen RC, et al. Genemarking to trace origin of relapse after autologous bone-marrow transplantation. Lancet. 1993;341: 85-86.
4. - cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML Blood. 1994;83:3068-3076.
5. - hematopoietic stem cells in patients with metastatic breast cancer. Biol Blood Marrow Transplant. 2000;6:262-271.
6. Vescio R, Schiller G, Stewart AK, et al. Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma. Blood. 1999;93:1858-1868.
7. + cells: factors influencing component purity and yield. Transfusion. 2000;40:507-512.
8. Tricot G, Gazitt Y, Leemhuis T, et al. Collection, tumor contamination, and engraftment kinetics of highly purified hematopoietic progenitor cells to support high dose therapy in multiple myeloma. Blood. 1998;91:4489-4495.
9. Anderson KC, Andersen J, Soiffer R, et al. Monoclonal antibody purged bone marrow transplanta Son theraoy for multiple myeloma. Blood. 1993; 82:2568-2576.
10. Thirukkumaran CM, Luider JM, Stewart DA, et al. Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation. Blood, 2003;102:377-387.
11. Teoh G, Chen L, Urashima M, et al. Adenovirus vector-based purging of multiple myeloma cells. Blood. 1998;92:4591-4601.
12. Soboloff J, Zhang Y, Minden M, Berger SA. Sensitivity of myeloid leukemia cells to calcium influx blockade: application to bone marrow purging. Exp Hematol. 2002;30:1219-1226.
13. Anderson GS, Tsujino I, Miyagi K, Sampson R. Sieber F. Preferential inactivation of paedriatic solid tumor cells by sequential exposure to Merocyanine 540-mediated photodynamic therapy and Edelfosine: implications for the ex vivo purging of autologous hematopoietic stem cell grafts. J Photochem Photobiol B. 2003;69:87-95.
14. Lundell BI, Vredenburgh JJ, Tyer C, DeSombre K, Smith AK. Ex vivo expansion of bone marrow from breast cancer patients: reduction in tumor cell content through passive purging. Bone Marrow Transplant. 1998;22:153-159.
15. Bierman PJ, Sweetenham JW, Loberiza Jr FR, et al. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation - The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. J Clin Oncol. 2003;21:3744-3753.
16. Eppich HM, Foxall R, Gaynor K. Pulsed electric fields for selection of hematopoietic cells and depletion of tumor cell contaminants. Nat Biotechnol. 2000;18:882-887.
17. Tsong TY. Electrically stimulated membrane breakdown. In: Lynch PT, Davey MR, eds. Electrical Manipulation of Cells. New York, NY: Chapman & Hall; 1996:15-37.
18. Sale AJH, Hamilton WA, Sale AJ, Hamilton WA. Effects of high electric fields on micro-organisms. Biochim Biophys Acta. 1968;163:37-43.
19. Radley JM, Ellis S, Palatsides M, Williams B, Bertoncello I. Ultrastructure of primitive hematopoietic stem cells isolated using probes of functional status. Exp Hematol. 1999;27:365-369.
20. Berardi AC, Wang A, Levine JD, Lopez P, Scadden DT. Functional isolation and characterization of human hematopoietic stem cells. Science. 1995;267:104-108.
21. Wang Z, Miura N, Bonelli A, et al. Receptor tyrosine kinase, EphB4 (HTK), accelerates differentiation of select human hematopoietic cells. Blood. 2002;99:2740-2747.